Blood Purification Devices Market (By Type: Portable, Stationary; By Application: Continuous blood purification, Hemoperfusion, Hemodialysis; By End-use: Hospitals, Clinics, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

Category : Healthcare and Pharmaceuticals | Published at : February-2021 | Delivery Format : PDF | Status: Published | Pages : 190

The global blood purification devices market is expected to grow at a CAGR of around 3.8% from 2020 to 2027 and expected to reach the market value of around US$ 5,502.6 Mn by 2027.

Blood purification devices are effective in treating certain patients by reducing various pathogens, cytokines, and other inflammatory mediators. Blood purification devices involve filtration process that controls cells immune response by reducing various pathogens, cytokines, and other inflammatory mediators that are small active proteins in the bloodstream by filtering the blood and returning the filtered blood to the patient's body. Rising support from the FDA regarding product approvals, the global blood purification devices is anticipated to surpass a notable market revenue growth. Significant rise in prevalence of diabetes and high blood pressure leading to chronic kidney diseases are the prominent factors that fuel the market growth of blood purification devices market globally.

Market drivers

High prevalence of chronic kidney disease (CKD) will boost demand for blood purification devices 

With chronic kidney disease (CKD) becoming damage over time they cannot clean the blood when compared with healthy kidneys. Therefore, people with CKD suffer from health problems that include heart disease and high blood pressure. According to the Center for Disease Control and Prevention (CDC), 15% of US adults that is 37 million people suffer from CKD. CKD is more prevalent in people aged 65 years or older (38%) than people with age group 45-64 years (13%) and 18-44 years (7%). 

Therapeutic advancements in technology is a trend

In April 2020, the USFDA issued an Emergency Use Authorization (EUA) to cytosorbents for its cytosorb technology to be used with COVID-19 patients. Such rigorous approvals are led to treat the disease by various product offerings by the market players. In COVID1-19, a new blood filtration technology has successfully treated hyper-vigilant immune syndrome for people who underwent surgery and are critically ill. This proves as an effective therapy for some severe COVID-19 cases. Moreover, in July 2020, Baxter India, a subsidiary of the American Healthcare company Baxter International, announced that the Central Drug Standard Control Organization (CDSCO) has given approval to its blood purification filter oxiris for the treatment of COVID-19 patients. The new product is designed such that it can remove three different things from blood. These includes cytokines, endotoxins (toxins produced by some kinds of bacteria), and uremic toxins (toxins that stay in the body due to improper functioning of kidneys). The product is specialized such that it helps both sepsis patients and patients requiring continuous renal replacement therapy.  

Rigorous product approvals in COVID-19 by FDA witness stupendous growth opportunities for blood purification devices market

In April 2020, the USFDA grant its first emergency use authorization (EUA) for a blood purification system to treat patients at risk for respiratory failure owing to COVID-19. The EUA was granted to Terumo BCT Inc. and Marker Therapeutics authorized for the use of their Spectra Optia Apheresis System and Depuro D2000 Adsorption Cartridge devices that are involved in filtration of cytokines and other inflammatory proteins from patient’s blood. Further, EUA restricts the use of device to patients less than 18 years that are admitted to an intensive care unit (ICU) with confirmed or imminent respiratory failure. Moreover, it specifies that the devices should only be utilized for patients with early acute lung injury, early acute respiratory distress syndrome, and other specific severe or life-threatening symptoms or conditions.

Segmental Outlook

Blood purification devices market is segmented based on type, application, and end-user. By type, the market is bifurcated as portable and stationary. By application, the market is categorized as continuous blood purification, hemoperfusion, and hemodialysis. By end-user the market is segregated as hospitals, clinics, and others.

Portable blood purification equipment will record significant share in the forthcoming years

Portable equipments are majorly preferred by the professionals that are actively involved in continuous blood purification process. Portability equipment allows efficient treatment in emergency cases. Moreover, portable equipments are sort of compact and occupy minimum space that leads to high adoption during the blood purification process. The device removes dirty blood from the body, separates harmful agents, and returns clean blood to the body in a similar fashion to dialysis in treatment of kidney failure.

Hospitals Segment will achieve notable growth for the blood purification devices market worldwide

Hospitals witness immense growth opportunities during the analysis timeframe. Hospitals are well-equipped with medical devices and equipment. Blood purification devices services delivered at hospitals assure fast recovery as these are attached to international standards. Therefore, people suffering from renal failure usually prefer blood purification from hospitals resulting for the business growth.

Hemodialysis Segment will offer lucrative growth opportunities for the market growth of blood purification devices in the forthcoming years

Substantial segmental growth is witnessed owing to surge in cases of diabetes that affects kidney functioning. Currently available blood purification devices are highly efficient and assist in recovering the kidney functions. Such growth factors coupled with growing awareness regarding blood purification in developing economies bolster the growth of the blood purification devices market worldwide.

Regional Overview

North America is projected to dominate the blood purification devices market globally followed by Asia Pacific. Fast product approvals by the USFDA, government involvement to tackle situation of COVID-19 by product offerings in the global market enhance the growth of blood purification device market. Additionally, favorable demographic trend such as ever growing geriatric population led to high demand for blood purification device market that has a positive influence for the growth of overall market. Positive regulatory scenario for blood purification devices triggers the regional market growth.

Asia Pacific will record significant growth in the coming years

Asia Pacific is also gaining fast pace in the blood purification device regional market. Growth of this region involves high adoption of the several products in various medical diagnostic and treatment procedures. Moreover, rising number of disease related to kidney disorders and lifestyle disorders like diabetes and cardiac dysfunction, technological advancements in blood collection tubes coupled with filtration techniques are the factors that are impacted positively for the growth of blood purification devices market. Also, WHO and Japanese Society for Dialysis Therapy, National Blood Authority (NBA), and Red Cross Society are the few authorized body are impacted strongly for the regional growth of Asia Pacific blood purification devices market.

Competitive Landscape

Key companies profiled in this report involve Accel Diagnostics, Aethlon Medical, Cerus Company, Circle Biologics, CytoSorbents, Jafron, Medtronic, NxStage Medical, Spectral Medical, Stellarray, Toray Medica, and among others.

Market Segmentation

Market By Type



Market By Application

Continuous blood purification



Market By End-use




Market By Geography

North America

  • U.S.
  • Canada


  • U.K.
  • Germany
  • France
  • Spain
  • Rest of Europe


  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Frequently Asked Questions

Blood purification device market is expected to reach a market value of around US$ 5,502.6 Mn by 2027.

The blood purification device market is expected to grow at a CAGR of around 3.8% from 2020 to 2027

Based on type, portable blood purification equipment is the leading segment in the overall market.

High government involvement and fast product approval drives the demand for blood purification device market.

Accel Diagnostics, Aethlon Medical, Cerus Company, Circle Biologics , CytoSorbents, Jafron, Medtronic, NxStage Medical, Spectral Medical, Stellarray, Toray Medica, and among others.

North America is anticipated to grab the highest market share in the regional market

Asia Pacific is expected to be the fastest growing market in the forthcoming years

Cart Summary